Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Preferred Stock Liabilities (2023)

Metagenomi (MGX) has disclosed Preferred Stock Liabilities for 1 consecutive years, with $350.8 million as the latest value for Q4 2023.

  • Quarterly Preferred Stock Liabilities changed N/A to $350.8 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $350.8 million through Dec 2023, changed N/A year-over-year, with the annual reading at $350.8 million for FY2023, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q4 2023 was $350.8 million at Metagenomi, roughly flat from $350.8 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $350.8 million in Q1 2023, with the low at $350.8 million in Q1 2023.